CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies

• Egile Nagusiak: Manuel González de Aledo (Egilea), Mónica González-Bardanca (Egilea), Lucía Blasco (Egilea), Olga Pacios (Egilea), Inés Bleriot (Egilea), Laura Fernández-García (Egilea), Melisa Fernández-Quejo (Egilea), María López (Egilea), Germán Bou (Egilea), María Tomás (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2021-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

One of the biggest threats we face globally is the emergence of antimicrobial-resistant (AMR) bacteria, which runs in parallel with the lack in the development of new antimicrobials. Among these AMR bacteria pathogens belonging to the ESKAPE group can be highlighted (<i>Enterococcus</i>...